Literature DB >> 15483650

Evaluation of NSD2 and NSD3 in overgrowth syndromes.

Jenny Douglas1, Kim Coleman, Katrina Tatton-Brown, Helen E Hughes, I Karen Temple, Trevor R P Cole, Nazneen Rahman.   

Abstract

Sotos syndrome is an overgrowth condition predominantly caused by truncating mutations, missense mutations restricted to functional domains, or deletions of NSD1. NSD1 is a member of a protein family that includes NSD2 and NSD3, both of which show 70-75% sequence identity with NSD1. This strong sequence similarity suggests that abrogation of NSD2 or NSD3 function may cause non-NSD1 Sotos cases or other overgrowth phenotypes. To evaluate this hypothesis, we mutationally screened NSD2 and NSD3 in 78 overgrowth syndrome cases in which NSD1 mutations and deletions had been excluded. Additionally, we used microsatellite markers within the vicinity of the genes to look for whole gene deletions. No truncating mutations or gene deletions were identified in either gene. We identified two conservative missense NSD2 alterations in two non-Sotos overgrowth cases but neither was within a functional domain. We identified three synonymous and two intronic variants in NSD2 and two synonymous base substitutions in NSD3. Our results suggest that despite strong sequence similarity between NSD1, NSD2 and NSD3, the latter genes are unlikely to be making a substantial contribution to overgrowth phenotypes and thus may operate in distinct functional pathways from NSD1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15483650     DOI: 10.1038/sj.ejhg.5201298

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

Review 1.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Clinical and molecular heterogeneity in brazilian patients with sotos syndrome.

Authors:  Gustavo H Vieira; Melissa M Cook; Renata L Ferreira De Lima; Carlos E Frigério Domingues; Daniel R de Carvalho; Isaias Soares de Paiva; Danilo Moretti-Ferreira; Anand K Srivastava
Journal:  Mol Syndromol       Date:  2015-01-21

3.  The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.

Authors:  Shaila Rahman; Mathew E Sowa; Matthias Ottinger; Jennifer A Smith; Yang Shi; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2011-05-09       Impact factor: 4.272

4.  Everybody's welcome: The big tent approach to epigenetic drug discovery.

Authors:  Erin M Green; Or Gozani
Journal:  Drug Discov Today Ther Strateg       Date:  2011-09-20

5.  The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.

Authors:  Chao He; Fudong Li; Jiahai Zhang; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2012-12-26       Impact factor: 5.157

6.  Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

Authors:  Katrina Tatton-Brown; Jenny Douglas; Kim Coleman; Genevieve Baujat; Trevor R P Cole; Soma Das; Denise Horn; Helen E Hughes; I Karen Temple; Francesca Faravelli; Darrel Waggoner; Seval Turkmen; Valerie Cormier-Daire; Alexandre Irrthum; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2005-06-07       Impact factor: 11.025

7.  Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.

Authors:  Eric di Luccio
Journal:  J Cancer Prev       Date:  2015-06

Review 8.  The interplay of histone modifications - writers that read.

Authors:  Tianyi Zhang; Sarah Cooper; Neil Brockdorff
Journal:  EMBO Rep       Date:  2015-10-15       Impact factor: 8.807

9.  5q35 duplication presents with psychiatric and undergrowth phenotypes mediated by NSD1 overexpression and mTOR signaling downregulation.

Authors:  Fabiola Quintero-Rivera; Celeste C Eno; Christine Sutanto; Kelly L Jones; Małgorzata J M Nowaczyk; Derek Wong; Dawn Earl; Ghayda Mirzaa; Anita Beck; Julian A Martinez-Agosto
Journal:  Hum Genet       Date:  2021-01-03       Impact factor: 4.132

Review 10.  Sotos syndrome.

Authors:  Geneviève Baujat; Valérie Cormier-Daire
Journal:  Orphanet J Rare Dis       Date:  2007-09-07       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.